4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-035499
Chief Medical Officer sold 1,343 shares at $11.83 ($15,888)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kerr Douglas Chief Medical Officer | 2025-03-05 | Sale 10b5-1 | −1,343 | $11.83 | $15,888 | 94,157 | D |
| Open-market sales · 1,343 sh · avg $11.83 · $15,888 | |||||||
Loading xslF345X05/ownership.xml…